Nephrotic Syndrome
📧 Sign up to get email alerts when something new happens for Nephrotic Syndrome.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2009-05-04FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for furosemide from Hikma Pharmaceuticals USA Inc., updating the labeling on an existing product.
-
FDA approval · 2009-05-04FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for furosemide submitted by Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2009-04-30FDA Approved: SPIRONOLACTONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries, Inc.'s supplemental ANDA for spironolactone, granting approval of their generic product for the …
-
FDA approval · 2009-03-12FDA Approved: FUROSEMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for furosemide submitted by Chartwell RX, LLC, resulting in updated labeling for the product.
-
FDA approval · 2009-02-25FDA Approved: SPIRONOLACTONE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for Spironolactone submitted by Mylan Pharmaceuticals Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-02-20FDA Approved: FUROSEMIDE — Supplemental Application (Solco Healthcare LLC)
The FDA approved a supplemental application for furosemide from Solco Healthcare LLC, adding a new manufacturing source for the product.
-
FDA approval · 2009-02-06FDA Approved: FUROSEMIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for furosemide submitted by Chartwell RX, LLC.
-
FDA approval · 2009-01-30FDA Approved: AMILORIDE HYDROCHLORIDE — Original Application (Sigmapharm Laboratories, LLC)
FDA approves Sigmapharm Laboratories, LLC's amiloride hydrochloride as an original generic application (ANDA) product space.
-
FDA approval · 2009-01-27FDA Approved: TORSEMIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' generic torsemide (Original Application), authorizing the generic torsemide tablet for edema associated…
-
FDA approval · 2008-08-15FDA Approved: HYDROCHLOROTHIAZIDE — Original Application (Exelan Pharmaceuticals Inc.)
The FDA approved Exelan Pharmaceuticals Inc.'s original application for hydrochlorothiazide, a generic diuretic indicated for hypertension a…
-
FDA approval · 2008-05-09FDA Approved: TORSEMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for torsemide by Chartwell RX, LLC, updating an approved generic product (ANDA).
-
FDA approval · 2008-04-10FDA Approved: TORSEMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved Chartwell RX, LLC's supplemental application for Torsemide, enabling the requested changes to the product's approval.
-
CLINICAL_TRIALS trial_result · 2008-04-09Clinical Trial Update: Drug Therapy in Lupus Nephropathy [Phase 2]
Phase 2 clinical trial evaluating a drug therapy for lupus nephropathy in nephrotic syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis [Phase 2]
Phase 2 clinical trial evaluating once-a-month steroid treatment for focal segmental glomerulosclerosis has completed.
-
CLINICAL_TRIALS research · 2007-11-29Clinical Trial Update: Long Term Tapering or Standard Steroids for Nephrotic Syndrome [Phase 4]
Phase 4 clinical trial comparing long-term tapering versus standard steroid regimens for nephrotic syndrome, sponsored by the Institute of C…
-
FDA approval · 2007-11-07FDA Approved: TORSEMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for torsemide from Chartwell RX, LLC, updating the label for this generic diuretic.
-
FDA approval · 2007-10-17FDA Approved: TORSEMIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original Abbreviated New Drug Application for torsemide from Rising Pharma Holdings, granting regulatory clearance for a ge…
-
FDA approval · 2007-10-03FDA Approved: TORSEMIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for Torsemide from Chartwell RX, LLC.
-
FDA approval · 2007-06-29FDA Approved: FUROSEMIDE — Supplemental Application (Leading Pharma, LLC)
FDA approves a supplemental application for furosemide submitted by Leading Pharma, LLC.
-
FDA approval · 2007-03-28FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s supplemental application for furosemide (a generic diuretic) under the ANDA.
-
FDA approval · 2007-03-28FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for furosemide by Hikma Pharmaceuticals USA Inc., approving regulatory action on an existing generic…
-
FDA approval · 2007-03-28FDA Approved: FUROSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for furosemide from Hikma Pharmaceuticals USA Inc., resulting in changes to the product labeling…
-
FDA approval · 2006-09-18FDA Approved: FUROSEMIDE — Original Application (Ipca Laboratories Limited)
FDA approved the Original Application for furosemide from Ipca Laboratories Limited, enabling a generic version of the diuretic to be market…
-
CLINICAL_TRIALS trial_result · 2006-08-10Clinical Trial Update: Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome [Phase 2, Phase 3]
A phase 2/phase 3 clinical trial evaluated tacrolimus in combination with prednisone for idiopathic membranous nephropathy and nephrotic syn…